Responding to stimulant use — developments in treatment
Objective: To better understand current developments in the treatment of stimulant use.
Background: Stimulant drugs are second only to cannabis as the most widely used class of illicit drug globally, accounting for 68 million past-year consumers.
In Europe, according to the latest data of the EMCDDA’s European Drug Report 2022, surveys in 25 EU countries between 2016 and 2021 suggest that 1.4 million young adults (15–34) used amphetamines during the last year (1.4 % of this age group). More than 8 000 clients entering specialised drug treatment in Europe in 2020 reported amphetamine...